← Research
Dec 2016 Randomized Controlled Trial
Psilocybin Produces Substantial and Sustained Decreases in Depression and Anxiety in Patients With Life-Threatening Cancer: A Randomized Double-Blind Trial
Griffiths RR, Johnson MW, Carducci MA, et al. — Johns Hopkins University School of Medicine
Published in Journal of Psychopharmacology
51 cancer patients with life-threatening diagnoses received a high dose (22 or 30 mg/70kg) and a low dose of psilocybin in a crossover design. High-dose sessions produced large decreases in depression and anxiety; at 6-month follow-up, roughly 80% still showed clinically significant improvement.
Read the Full Paper at Journal of Psychopharmacology